Table 3: Outcome measures, side effects and treatment sequence allocations.
| Outcome | Treatment sequence | Estimates | Treatment period | Mc-Memar test (p-value) | |
| 1 | 2 | ||||
| Period 1 | Period 2 | ||||
| Headache | Morning-evening | N | 1 | 0 | 0.62 |
| Sample size | 8 | 8 | |||
| Evening-morning | N | 3 | 0 | ||
| Sample size | 10 | 9 | 0.99 | ||
| Cough | Morning-evening | N | 2 | 0 | |
| Sample size | 8 | 8 | |||
| Evening-morning | N | 1 | 0 | ||
| Sample size | 10 | 9 | |||
| Lipothymia | Morning-evening | N | 0 | 0 | NA |
| Sample size | 8 | 8 | |||
| Evening-morning | N | 0 | 0 | ||
| Sample size | 10 | 9 | |||
| Vertigo | Morning-evening | N | 0 | 0 | 0.48 |
| Sample size | 8 | 8 | |||
| Evening-morning | N | 2 | 0 | ||
| Sample size | 10 | 9 | |||